Cargando…
Receptor variants and the development of centrally acting medications
The progressive changes in research paradigms observed in the largest pharmaceutical companies and the burgeoning of biotechnology startups over the last 10 years have generated a need for outsourcing research facilities. In parallel, progress made in the fields of genomics, protein expression in re...
Autores principales: | Neale, Stuart A., Kambara, Kumiko, Salt, Thomas E., Bertrand, Daniel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Les Laboratoires Servier
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6787545/ https://www.ncbi.nlm.nih.gov/pubmed/31636489 http://dx.doi.org/10.31887/DCNS.2019.21.2/dbertrand |
Ejemplares similares
-
The molecular mechanism of snake short-chain α-neurotoxin binding to muscle-type nicotinic acetylcholine receptors
por: Nys, Mieke, et al.
Publicado: (2022) -
Relative nutritional deficiencies associated with centrally acting monoamines
por: Hinz, Marty, et al.
Publicado: (2012) -
Neuronal activity patterns in the mediodorsal thalamus and related cognitive circuits are modulated by metabotropic glutamate receptors
por: Copeland, C.S., et al.
Publicado: (2015) -
Cannabinoids Alleviate Experimentally Induced Intestinal Inflammation by Acting at Central and Peripheral Receptors
por: Fichna, Jakub, et al.
Publicado: (2014) -
Modulation of the Erwinia ligand-gated ion channel (ELIC) and the 5-HT(3) receptor via a common vestibule site
por: Brams, Marijke, et al.
Publicado: (2020)